A large number of studies have shown that the topical application of TRPV3 inhibitors can effectively inhibit skin pruritus and pain, which provides a new idea for the treatment of intractable pruritus and pain diseases such as Olmsted syndrome and hereditary palmoplantar keratosis. The gene discussed is TRPV3; the disease is Olmsted syndrome 1.